Abstract

δ-opioid receptor agonists mobilize intracellular Ca2+([Ca2+]i) in SH-SY5Y cells when applied in the presence of muscarinic agonists. The putative δ1 receptor agonist [D-Pen2,D-Pen5]-enkephalin (DPDE) elevated [Ca2+]i with an EC50 of 11 nM and the putative δ2 agonist deltorphin II elevated [Ca2+]i, with an EC50 of 14 nM. The maximal elevations of [Ca2+]i caused by both agonists were not different, nor were maximally effective concentrations of DPDPE (1 μM) and deltorphin II (1 μM) applied together more effective than either agonist applied alone. The elevations of [Ca2+]i caused by DPDPE (1 μM) and deltorphin II (1 μM), in the presence of carbachol, desensitized rapidly with continued opioid exposure and the cross-desensitization between DPDPE and deltorphin II was complete. The putative δ1 selective antagonist 7-benzylidenenaltrexone (BNTX) and the putative δ2 selective antagonist naltriben both reduced the elevations of [Ca2+]i caused by DPDPE (30 nM) and deltorphin II (10 nM), by greater than 50% at concentrations of less than 10 nM. In SH-SY5Y cells δ-receptor mediated elevation of [Ca2+]i is mediated by a population of receptors, which does not discriminate between agonists and antagonists purportedly selective for δ1 or δ2 receptors. © 1997 Elsevier Science Ltd. All rights reserved.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.